Literature DB >> 31710713

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters.

Stephen P H Alexander1, Eamonn Kelly2, Alistair Mathie3, John A Peters4, Emma L Veale3, Jane F Armstrong5, Elena Faccenda5, Simon D Harding5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5.   

Abstract

The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.14753. Transporters are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein-coupled receptors, ion channels, nuclear hormone receptors, catalytic receptors and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2019, and supersedes data presented in the 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
© 2019 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society.

Entities:  

Year:  2019        PMID: 31710713      PMCID: PMC6844579          DOI: 10.1111/bph.14753

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  2 in total

1.  Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain.

Authors:  Yuri Kato; Miki Hiasa; Reiko Ichikawa; Nao Hasuzawa; Atsushi Kadowaki; Ken Iwatsuki; Kazuhiro Shima; Yasuo Endo; Yoshiro Kitahara; Tsuyoshi Inoue; Masatoshi Nomura; Hiroshi Omote; Yoshinori Moriyama; Takaaki Miyaji
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

2.  Slc12a8 is a nicotinamide mononucleotide transporter.

Authors:  Alessia Grozio; Kathryn F Mills; Jun Yoshino; Santina Bruzzone; Giovanna Sociali; Kyohei Tokizane; Hanyue Cecilia Lei; Richard Cunningham; Yo Sasaki; Marie E Migaud; Shin-Ichiro Imai
Journal:  Nat Metab       Date:  2019-01-07
  2 in total
  78 in total

1.  Inhibition of heparanase protects against pancreatic beta cell death in streptozotocin-induced diabetic mice via reducing intra-islet inflammatory cell infiltration.

Authors:  Wen-Yu Song; Xiao-Han Jiang; Ying Ding; Yan Wang; Ming-Xuan Zhou; Yun Xia; Chen-Yu Zhang; Chong-Chong Yin; Chen Qiu; Kai Li; Peng Sun; Xiao Han
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

2.  Population pharmacokinetics, efficacy, and safety of moxetumomab pasudotox in patients with relapsed or refractory hairy cell leukaemia.

Authors:  Denison Kuruvilla; Yen Lin Chia; Kemal Balic; Nai Shun Yao; Robert J Kreitman; Ira Pastan; Xia Li; Nathan Standifer; Meina Liang; Chih-Ming Tseng; Raffaella Faggioni; Lorin Roskos
Journal:  Br J Clin Pharmacol       Date:  2020-03-16       Impact factor: 4.335

3.  Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation.

Authors:  Ana Carolina Moreira Souza; Andrea Grabe-Guimarães; Jader Dos Santos Cruz; Artur Santos-Miranda; Charlotte Farah; Liliam Teixeira Oliveira; Alexandre Lucas; Franck Aimond; Pierre Sicard; Vanessa Carla Furtado Mosqueira; Sylvain Richard
Journal:  Br J Pharmacol       Date:  2020-08-24       Impact factor: 8.739

4.  Gonadal hormone-independent sex differences in GABAA receptor activation in rat embryonic hypothalamic neurons.

Authors:  Franco R Mir; Carlos Wilson; Lucas E Cabrera Zapata; Luis G Aguayo; María Julia Cambiasso
Journal:  Br J Pharmacol       Date:  2020-04-03       Impact factor: 8.739

Review 5.  Exploring microRNAs in diabetic chronic cutaneous ulcers: Regulatory mechanisms and therapeutic potential.

Authors:  Xuqiang Nie; Jiufeng Zhao; Hua Ling; Youcai Deng; Xiaohui Li; Yuqi He
Journal:  Br J Pharmacol       Date:  2020-08-13       Impact factor: 8.739

6.  Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway.

Authors:  Liwei Wu; Wenhui Mo; Jiao Feng; Jingjing Li; Qiang Yu; Sainan Li; Jie Zhang; Kan Chen; Jie Ji; Weiqi Dai; Jianye Wu; Xuanfu Xu; Yuqing Mao; Chuanyong Guo
Journal:  Br J Pharmacol       Date:  2020-06-27       Impact factor: 8.739

Review 7.  Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.

Authors:  Joana Bicker; Gilberto Alves; Amílcar Falcão; Ana Fortuna
Journal:  Br J Pharmacol       Date:  2020-03-20       Impact factor: 8.739

Review 8.  Functional marriage in plasma membrane: Critical cholesterol level-optimal protein activity.

Authors:  Ulises Meza; Mayra Delgado-Ramírez; Catalina Romero-Méndez; Sergio Sánchez-Armass; Aldo A Rodríguez-Menchaca
Journal:  Br J Pharmacol       Date:  2020-03-24       Impact factor: 8.739

Review 9.  Managing Parkinson's disease: moving ON with NOP.

Authors:  Daniela Mercatelli; Erwan Bezard; Roberto Eleopra; Nurulain T Zaveri; Michele Morari
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

10.  Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat.

Authors:  Annette E Allen; Elizabeth A Martin; Katherine Greenwood; Claire Grant; Peter Vince; Robert J Lucas; William S Redfern
Journal:  Br J Pharmacol       Date:  2020-09-13       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.